Division of Allergy and Clinical Immunology, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
J Am Acad Dermatol. 2013 Sep;69(3):407-15. doi: 10.1016/j.jaad.2013.03.024. Epub 2013 Apr 28.
The liver is the most commonly involved internal organ in drug-induced systemic hypersensitivity. However, data obtained from these patients have yet to be analyzed in depth with respect to liver injury.
The medical records of 136 patients who developed delayed-type drug hypersensitivity were reviewed at a tertiary referral hospital. Culprit drugs, the pattern and degree of liver injury, and the effect of systemic corticosteroids were evaluated in the group of patients with drug-induced systemic hypersensitivity and liver dysfunction (aspartate aminotransferase or alanine aminotransferase ≥80 IU/L). Clinical characteristics of patients with drug-induced systemic hypersensitivity and liver injury were analyzed.
Among the 61 patients with drug-induced systemic hypersensitivity and liver dysfunction, the clinical phenotypes were drug reaction with eosinophilia and systemic symptoms (n = 29, 48%), Stevens-Johnson syndrome/toxic epidermal necrolysis (n = 11, 18%), and maculopapular rash (n = 17, 28%). Antibiotics (n = 27, 44%) were the most common cause of drug-induced systemic hypersensitivity with liver dysfunction. Whereas patients with Stevens-Johnson syndrome/toxic epidermal necrolysis had mild hepatocellular-type liver injury of relatively brief duration, those with drug reaction with eosinophilia and systemic symptoms/drug-induced hypersensitivity syndrome had more severe and prolonged hepatocellular injury in addition to moderate to severe cholestatic-type liver injury. The use of systemic corticosteroids did not significantly affect either recovery from liver injury or mortality.
This study was retrospective and the number of subjects was small.
The results suggest that the severity, pattern, and duration of liver injury differ according to the drug-hypersensitivity phenotype. Further studies are needed to evaluate the role of systemic corticosteroids in drug-induced systemic hypersensitivity and liver injury.
肝脏是药物引起的全身性过敏反应中最常受累的内脏器官。然而,尚未对这些患者的肝损伤数据进行深入分析。
在一家三级转诊医院回顾了 136 例发生迟发性药物超敏反应患者的病历。评估了药物引起的全身性过敏反应和肝功能障碍(天门冬氨酸氨基转移酶或丙氨酸氨基转移酶≥80IU/L)患者组中的致敏药物、肝损伤的模式和程度以及全身性皮质类固醇的效果。分析了药物引起的全身性过敏反应和肝损伤患者的临床特征。
在 61 例药物引起的全身性过敏反应和肝功能障碍患者中,临床表型为药物反应伴嗜酸性粒细胞增多和全身症状(n=29,48%)、史蒂文斯-约翰逊综合征/中毒性表皮坏死松解症(n=11,18%)和斑丘疹(n=17,28%)。抗生素(n=27,44%)是引起药物引起的全身性过敏反应伴肝功能障碍的最常见原因。史蒂文斯-约翰逊综合征/中毒性表皮坏死松解症患者肝损伤为轻度肝细胞型,持续时间相对较短,而药物反应伴嗜酸性粒细胞增多和全身症状/药物超敏反应综合征患者除中重度胆汁淤积型肝损伤外,还存在更严重和持续时间更长的肝细胞损伤。全身性皮质类固醇的使用并未显著影响肝损伤的恢复或死亡率。
本研究为回顾性研究,且研究对象数量较少。
结果表明,肝损伤的严重程度、模式和持续时间因药物过敏表型而异。需要进一步研究评估全身性皮质类固醇在药物引起的全身性过敏反应和肝损伤中的作用。